Teriparatide 20 mcg injection prices vary significantly depending on factors such as the manufacturer, pharmacy, insurance coverage, and geographic location. As a brand-name drug, it can be expensive.
How much does brand-name Forteo cost?
The brand-name formulation of teriparatide, Forteo, can cost several thousand dollars for a 30-day supply. For example, without insurance, a 2.4 mL (80 mcg/0.8 mL) prefilled pen might range from approximately $3,000 to over $6,000. Prices fluctuate and are subject to change.
What are the costs for generic teriparatide injections?
Generic versions of teriparatide are available and generally offer a lower price point compared to the brand-name Forteo. However, the cost of generics also varies. A 2.4 mL prefilled pen of generic teriparatide could cost anywhere from around $500 to $2,000 or more, depending on the specific product and provider.
How does insurance affect the price of teriparatide?
Insurance plans can substantially reduce the out-of-pocket cost of teriparatide. Many insurance providers cover either the brand-name or generic versions, though coverage details, copays, and deductibles will differ by plan. Patients are advised to check with their insurance provider for specific coverage information and potential savings programs.
Are there patient assistance programs available for teriparatide?
Yes, manufacturers of both brand-name and generic teriparatide may offer patient assistance programs or discount cards to eligible individuals who lack adequate insurance coverage or face high costs. These programs can lower the price of the medication. For instance, the manufacturer of Forteo may have savings card options.
When does the patent for Forteo expire?
The primary patents for Forteo have expired, which paved the way for the development and approval of generic teriparatide products. DrugPatentWatch.com tracks patent expiries and the introduction of generics for many medications.
What are the approved uses for teriparatide injections?
Teriparatide injections are primarily prescribed for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture. It is also used to treat osteoporosis in men and women who have hip or vertebral fractures or multiple risk factors for fracture. Additionally, it is indicated for men and women with glucocorticoid-induced osteoporosis.